Skip to content

Hearing

June 25, 2025 Health Subcommittee Chairman Buchanan Opening Statement: Hearing on Harnessing the Power of Digital Health Data

Today, Ways and Means Health Subcommittee Chairman Vern Buchanan (FL-16) delivered the following remarks during a hearing on harnessing the…

Read More (Health Subcommittee Chairman Buchanan Opening Statement: Hearing on Harnessing the Power of Digital Health Data)
June 13, 2025 Six Key Moments: Hearing with Treasury Secretary Scott Bessent 

WASHINGTON, D.C. – President Trump’s economic agenda – lower taxes, fairer trade, and deregulation – will help working class Americans and…

Read More (Six Key Moments: Hearing with Treasury Secretary Scott Bessent )
June 11, 2025 Chairman Smith at Secretary Bessent Hearing: President’s Economic Agenda Igniting New Era of Prosperity

Today, Ways and Means Committee Chairman Jason Smith (MO-08) delivered the following remarks at a hearing with Treasury Secretary Scott…

Read More (Chairman Smith at Secretary Bessent Hearing: President’s Economic Agenda Igniting New Era of Prosperity)
April 11, 2025 Seven Key Moments: Hearing on President Trump’s Trade Agenda With Ambassador Jamieson Greer

WASHINGTON, D.C. – U.S. Trade Representative Jamieson Greer shared the transformational and historic trade actions taken by the Trump Administration during…

Read More (Seven Key Moments: Hearing on President Trump’s Trade Agenda With Ambassador Jamieson Greer)
April 10, 2025 Three Key Moments: Hearing on Government Watchdog Findings and Need for TANF Reform

WASHINGTON, D.C. – The Temporary Assistance for Needy Families (TANF) program is in need of greater accountability to prevent fraud and…

Read More (Three Key Moments: Hearing on Government Watchdog Findings and Need for TANF Reform)
April 10, 2025 Four Key Moments: Hearing on the Health of the Biosimilar Market

WASHINGTON, D.C. – Greater use of biosimilar medications offers a proven pathway to expand access to treatments and cut health care…

Read More (Four Key Moments: Hearing on the Health of the Biosimilar Market)